Page last updated: 2024-09-03

bmy 42393 and epoprostenol

bmy 42393 has been researched along with epoprostenol in 2 studies

Compound Research Comparison

Studies
(bmy 42393)
Trials
(bmy 42393)
Recent Studies (post-2010)
(bmy 42393)
Studies
(epoprostenol)
Trials
(epoprostenol)
Recent Studies (post-2010) (epoprostenol)
21011503

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brassard, CL; Buchanan, JO; Federici, ME; Fleming, JS; Gamberdella, M; Meanwell, NA; Rosenfeld, MJ; Trehan, AK; Wright, JJ; Zavoico, GB1
Brassard, CL; Buchanan, JO; Gougoutas, JZ; Malley, MF; Martin, SW; Meanwell, NA; Romine, JL; Rosenfeld, MJ; Trehan, AK; Wright, JJ1

Other Studies

2 other study(ies) available for bmy 42393 and epoprostenol

ArticleYear
Nonprostanoid prostacyclin mimetics. 2. 4,5-Diphenyloxazole derivatives.
    Journal of medicinal chemistry, 1992, Sep-18, Volume: 35, Issue:19

    Topics: Adenosine Diphosphate; Cell Membrane; Humans; Oxazoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Structure-Activity Relationship

1992
Nonprostanoid prostacyclin mimetics. 5. Structure-activity relationships associated with [3-[4-(4,5-diphenyl-2-oxazolyl)-5- oxazolyl]phenoxy]acetic acid.
    Journal of medicinal chemistry, 1993, Nov-26, Volume: 36, Issue:24

    Topics: Acetates; Adenosine Diphosphate; Binding, Competitive; Crystallization; Epoprostenol; Humans; Hydrogen Bonding; Iloprost; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Molecular Structure; Oxazoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Epoprostenol; Receptors, Prostaglandin; Structure-Activity Relationship

1993